In cancer, MK2 signaling was dispensable for the survival of p53wt non-small-cell lung carcinoma cells [6]; however, we found that MK2 activity was necessary for the survival of p53wt glioblastoma cells. This evidence concerns the gene MAPKAPK2 and non-small cell lung carcinoma.